Literature DB >> 9444953

Rho proteins induce metastatic properties in vivo.

L del Peso1, R Hernández-Alcoceba, N Embade, A Carnero, P Esteve, C Paje, J C Lacal.   

Abstract

Rho proteins have been implicated in the regulation of multiple signal transduction processes. Some of the members of this family, including the rho gene from Aplysia californica and the human genes (rhoA, rhoB and rac-1), are proto-oncogenes since when properly mutated they can induce cell transformation, and the generated rho-transformed cells are tumorigenic when inoculated into mice. In addition to their tumorigenic activity, there is evidence suggesting that Rho proteins may contribute to the metastatic phenotype. However, all the experiments implicating Rho proteins or Rho-regulating proteins in the induction of metastatic potential are either indirect or have been performed in vitro. In this study we investigated whether cells transformed by rho oncogenes do have metastatic potential in vivo. We present evidence that cells transformed by the Aplysia californica rho gene, when injected directly into the blood stream are able to efficiently colonize lungs and secondary organs, consistent with the acquisition of the metastatic potential. Moreover, tumors derived from subcutaneous injections of these rho-transformed cells are also able to metastasize in distant organs, a strong support to the hypothesis that Rho proteins play a role in the metastatic phenotype. Finally, cells transformed by the human oncogenes dbl, vav and ost, three well-known guanine exchange factors for members of the Rho family, or cells transformed by the activated human rac-1 or rhoA genes do also have metastatic potential when injected into the blood stream. These results demonstrate that signaling pathways regulated by Rho proteins play an important role in the acquisition of the metastatic phenotype in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9444953     DOI: 10.1038/sj.onc.1201499

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  The insert region of Rac1 is essential for membrane ruffling but not cellular transformation.

Authors:  A E Karnoub; C J Der; S L Campbell
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

Review 2.  Role of mTOR signaling in tumor cell motility, invasion and metastasis.

Authors:  Hongyu Zhou; Shile Huang
Journal:  Curr Protein Pept Sci       Date:  2011-02       Impact factor: 3.272

Review 3.  The Rho GTPase signalling pathway in urothelial carcinoma.

Authors:  Solomon L Woldu; Ryan C Hutchinson; Laura-Maria Krabbe; Oner Sanli; Vitaly Margulis
Journal:  Nat Rev Urol       Date:  2017-11-14       Impact factor: 14.432

Review 4.  Rho GTPase signaling in inflammation and transformation.

Authors:  U G Knaus
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

5.  The expression of rho proteins decreases with human brain tumor progression: potential tumor markers.

Authors:  Marie-Annick Forget; Richard R Desrosiers; MaestroRolandaF Del; Robert Moumdjian; Daniel Shedid; France Berthelet; Richard Béliveau
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

6.  Oxyphilic and non-oxyphilic thyroid carcinoma cell lines differ in expressing apoptosis-related genes.

Authors:  E Allìa; P Cassoni; T Marrocco; M Volante; B Bussolati; M Wong; O H Clark; M Papotti
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

7.  Gene expression profiles of primary breast tumors maintained in distant metastases.

Authors:  Britta Weigelt; Annuska M Glas; Lodewyk F A Wessels; Anke T Witteveen; Johannes L Peterse; Laura J van't Veer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-09       Impact factor: 11.205

8.  A critical role for Rac1 in tumor progression of human colorectal adenocarcinoma cells.

Authors:  Carolina Espina; María Virtudes Céspedes; Miguel Angel García-Cabezas; María Teresa Gómez del Pulgar; Alicia Boluda; Lourdes García Oroz; Salvador A Benitah; Paloma Cejas; Manuel Nistal; Ramón Mangues; Juan Carlos Lacal
Journal:  Am J Pathol       Date:  2007-12-28       Impact factor: 4.307

Review 9.  [Value of targeted treatment for testicular cancer: from molecular approaches to clinical possibilities].

Authors:  A Martinschek; C G Ruf; C Sparwasser; H U Schmelz
Journal:  Urologe A       Date:  2008-10       Impact factor: 0.639

10.  ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences.

Authors:  Salvador Aznar Benitah; Pilar F Valerón; Juan Carlos Lacal
Journal:  Mol Biol Cell       Date:  2003-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.